SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 439,885 shares at $6.20 ($2.7M) on 2025-10-20, disclosed to the SEC on 2025-10-22.
Scheduled sale ($2.7M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.20 | 220,535 | $1.4M | 49.7% |
| 2 | $6.30 | 109,675 | $691K | 25.1% |
| 3 | $6.30 | 109,675 | $691K | 25.1% |
| Total | $6.25 avg | 439,885 | $2.7M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |
| VIR | SELL | 2025-10-07 | $5.8M | — | Filing → |